RxDoctor Payments Data

Linda McCormick, DO

Family Medicine · Blue Springs, MONPI 1518956507

Payments from drug & device makers

$712in general payments, 2019–2025

Across 39 payments — averaging $18.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$317
  • Pfizer$126
  • Novartis$46
  • Valeritas, Inc.$38
  • GSK$36
  • Insulet Corporation$24
  • plus $125 from 8 others

What the payments were for

  • Food & beverage$712100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$712 in reported general payments places this provider in the 55th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$273,445
Medicare patients
737
Services billed
3,667

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide107$135,149
OzempicSemaglutide71$79,307
JardianceEmpagliflozin45$53,168
EliquisApixaban35$50,776
JanuviaSitagliptin Phosphate43$45,441
Trelegy ElliptaFluticasone/Umeclidin/Vilanter43$39,995
XareltoRivaroxaban32$33,465
Fiasp FlextouchInsulin Aspart (Niacinamide)18$18,462
FarxigaDapagliflozin Propanediol15$13,952
TrulicityDulaglutide11$11,562
Repatha SureclickEvolocumab15$8,422
MyrbetriqMirabegron14$7,337
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$6,150
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$5,916
Levemir FlexpenInsulin Detemir35$5,795

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$18$79,30771 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Arnuity Ellipta$36$54,01289 claims
PfizerEliquis$126$50,77635 claims
MerckJanuvia$20$45,44143 claims
Astellas Pharma US IncMyrbetriq$18$7,33714 claims
AbbVieSynthroid$317$2,92734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Blue Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →